Around half of the survey participants (n = 32; 51%) would utilize the terminology “low-grade oncocytic tumor (LOT)” for an oncocytic tumor diffusely positive for keratin 7 and negative for KIT; 12 (19%) would diagnose it as oncocytoma or chromophobe RCC, and another 14 (22%) would report these lesions along with a differential diagnosis and with a comment stating that while the morphology and IHC are similar to those that have been described for LOT, the tumor has not been fully characterized and patient outcome associated with these tumors may not yet be fully understood. The gene discussed is KRT7; the disease is oncocytic adenoma.